Dyne Therapeutics Inc. (NASDAQ:DYN) is one of the 10 affordable biotech stocks to buy right now. On June 26, TD Cowen initiated its coverage of Dyne Therapeutics Inc. (NASDAQ:DYN), assigning a Buy rating to the stock The firm stated that the company's Force platform
Viridian Therapeutics Inc. (NASDAQ:VRDN) is one of the 10 affordable biotech stocks to buy right now. On June 30, Goldman Sachs increased its target price for Viridian Therapeutics Inc. (NASDAQ:VRDN) from $35 to $39, implying an adjusted upside potential in excess of 105%
Praxis Precision Medicines (PRAX) Enters Into Licensing and Research Collaboration With Remagine Labs Praxis Precision Medicines Inc. (NASDAQ:PRAX) is one of the 10 affordable biotech stocks to buy right now. On July 7, Praxis Precision Medicines Inc. (NASDAQ:PRAX) and Rem
Taysha Gene Therapies Inc. (NASDAQ:TSHA) is one of the 10 affordable biotech stocks to buy right now. On June 24, Taysha Gene Therapies Inc. (NASDAQ:TSHA) disclosed the pricing of an underwritten public offering of 32.5 million of its common stock, priced at $6 per share</
Crinetics Pharmaceuticals Inc. (NASDAQ:CRNX) is one of the 10 affordable biotech stocks to buy right now. On July 6, Crinetics Pharmaceuticals Inc. (NASDAQ:CRNX) and Vertex Pharmaceuticals announced that both companies have agreed to a definitive agreement, according to wh
Quick Read - Walmart's eCommerce surged 26% and JNJ's pharma sales grew 10%, yet JNJ's lower 30x P/E and 2% yield offer more compelling value. - With consumer sentiment near recessionary lows, Walmart's upper-income gains face a real stress test that JNJ's pipeline and 64-year...
Six companies, including United Airlines and J.B. Hunt, are set to release quarterly results following Wednesday's trading session. Six companies will report earnings after the close on Wednesday, including United Airlines Holdings (UAL), J.B. Hunt Transport Services (JBHT
UBS Wealth Management projects the S&P 500 to rise nearly 20% from current levels, citing strong cash flow and execution. UBS Wealth Management expects the S&P 500 to climb to 7,900 by the end of the year, reflecting a bullish outlook for U.S. equities. The forecast assume
Cooler-than-expected wholesale inflation boosts equities, fueling bets on Fed policy flexibility amid easing price pressures. U.S. equities climbed after wholesale inflation data came in below expectations, signaling potential relief for the Federal Reserve. The S&P 500, N
Quick Read - Matthew Rodriguez paid $50,000 for a signed BRK-B commemorative book, surpassing the $31,500 Buffett himself paid for his Omaha home in 1958. - Buffett matched every auction dollar, turning $1.3 million in book proceeds into $2.6 million for the Stephen Center, an...
ادخل بحساب جوجل لمشاركة رأيك والتفاعل مع الأخبار — بلا كلمة مرور.
إيميلك يبقى موثّقاً وخصوصيتك محفوظة.